Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 2

Results: 10

Comment on: "Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 147, doi. 10.1007/s40261-022-01245-4

By:

Dutta, Deep;
Mohindra, Ritin;
Misra, Anoop

Publication type:

Article

Response to Comment on: "Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 149, doi. 10.1007/s40261-022-01244-5

By:

Durga, Devarapalli Ranjani;
Mounika, Nadella;
Mudimala, Pravallika;
Adela, Ramu

Publication type:

Article

Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 119, doi. 10.1007/s40261-022-01243-6

By:

Plum-Mörschel, Leona;
Andersen, Lizette Ravn;
Hansen, Solvejg;
Hövelmann, Ulrike;
Krawietz, Patricia;
Kristensen, Niels Rode;
Lehrskov, Lars Lang;
Haahr, Hanne

Publication type:

Article

Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 129, doi. 10.1007/s40261-022-01242-7

By:

Ogura, Toru;
Shiraishi, Chihiro

Publication type:

Article

Correction to: Nonmetastatic Castration‑Resistant Prostate Cancer: Current Challenges and Trends.

Published in:

2023

By:

Figueiredo, Arnaldo;
Costa, Luís;
Maurício, Maria Joaquina;
Figueira, Luís;
Ramos, Rodrigo;
Martins-da-Silva, Carlos

Publication type:

Correction Notice

Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 97, doi. 10.1007/s40261-022-01238-3

By:

Kumar, S Sajith;
Bagepally, Bhavani Shankara;
Sasidharan, Akhil

Publication type:

Article

Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 141, doi. 10.1007/s40261-022-01228-5

By:

Wang, Jami;
Qian, Mollie F.;
Jeng, Michael R.;
Teng, Joyce M. C.

Publication type:

Article

Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 109, doi. 10.1007/s40261-022-01227-6

By:

Wentzell, Nadine;
Kollhorst, Bianca;
Reinold, Jonas;
Haug, Ulrike

Publication type:

Article

Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Published in:

2023

By:

Gourzoulidis, George;
Koulentaki, Maria;
Kattamis, Antonis;
Bouzani, Maria;
Giatra, Chara;
Chotzagiannoglou, Vassiliki;
Beletsi, Alexandra;
Kourlaba, Georgia

Publication type:

Correction Notice

Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.

Published in:

Clinical Drug Investigation, 2023, v. 43, n. 2, p. 85, doi. 10.1007/s40261-022-01235-6

By:

Cox, Katherine;
Ghebrehiwet, Merhawit;
Kee, Micah;
Rucker, Brayden;
Flores, Holly;
Ottwell, Ryan;
Vassar, Matt

Publication type:

Article